Austin, United States, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Surgical Staplers Market Size & Growth Analysis: According to SNS Insider, The Surgical Staplers Market was valued at USD 6.41 billion in 2025 and is projected to reach USD 10.87 billion by 2033, growing at a CAGR of 6.87% during the forecast period 2026-2033. The global burden of chronic diseases that require surgical intervention, rising surgical procedure volumes, and the growing acceptance of minimally invasive and laparoscopic surgeries are all f ...

Stryker Corporation (NYSE:SYK) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 27, Matthew O’Brien from Piper Sandler reiterated his Overweight rating on Stryker Corporation (NYSE:SYK) with a price target of $420. His target price estimate represents over 17% upside for investors. O’Brien shed light on the company’s new handheld orthopedic robot, identified as Mako RPS, after connecting with a physician who had seen the product. According to the initial stu ...

Stryker Corporation (SYK) reported fourth-quarter 2025 adjusted earnings per share (EPS) of $4.47, which beat the Zacks Consensus Estimate of $4.40 by 1.6%. The bottom line also improved 11.5% year over year. Our model estimate for the metric was pegged at $3.15 per share.GAAP EPS was $2.22, up 2.8% from the year-ago quarter’s level.For the full year, adjusted EPS gained 11.8% to $13.63. GAAP EPS was $8.40, up 8.2% from the year-ago level.Revenue DetailsRevenues totaled $7.17 billion, which beat the Zacks C ...

Core Insights - Stryker reported revenue of $7.17 billion for the quarter ended December 2025, reflecting an 11.4% increase year-over-year and surpassing the Zacks Consensus Estimate of $7.13 billion by 0.61% [1] - The company's EPS was $4.47, up from $4.01 in the same quarter last year, exceeding the consensus estimate of $4.40 by 1.71% [1] Financial Performance - International net sales reached $1.73 billion, slightly above the average estimate of $1.72 billion, marking a year-over-year increase of 10.7% [4] - U.S. net sales were reported at $5.44 billion, matching the average estimate and showing an 11.7% increase year-over-year [4] - MedSurg and Neurotechnology sales totaled $4.56 billion, exceeding the estimated $4.53 billion, with a significant year-over-year growth of 17.5% [4] Segment Analysis - Orthopaedics sales amounted to $2.61 billion, aligning with estimates and reflecting a 2.2% year-over-year increase [4] - Within Orthopaedics, hips sales were $499 million, slightly below the estimated $504.79 million, but still showing a 7.8% increase year-over-year [4] - Trauma and Extremities sales were $1.09 billion, below the estimated $1.1 billion, with a year-over-year growth of 9% [4] Key Metrics - Stryker's stock has returned 1.8% over the past month, outperforming the Zacks S&P 500 composite's 0.8% change [3] - The company holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Medical equipment maker Stryker raised its full-year profit forecast on Thursday, banking on strong sales of its implants and other medical devices. ...

Stryker (NYSE:SYK) Q4 2025 Earnings call January 29, 2026 04:30 PM ET Company ParticipantsDavid Roman - Managing DirectorJason Beach - VP of Finance and Head of Investor RelationsJoanne Wuensch - Managing DirectorKevin Lobo - Chair and CEOPatrick Wood - Managing DirectorPreston Wells - CFORichard Newitter - Managing DirectorConference Call ParticipantsCaitlin Roberts - AnalystChris Pasquale - AnalystDanielle Antalffy - AnalystDrew Ranieri - AnalystJeff Johnson - AnalystLarry Biegelsen - Senior AnalystMatt M ...

Stryker (NYSE:SYK) Q4 2025 Earnings call January 29, 2026 04:30 PM ET Company ParticipantsDavid Roman - Managing DirectorJason Beach - VP of Finance and Head of Investor RelationsJoanne Wuensch - Managing DirectorKevin Lobo - Chair and CEOPatrick Wood - Managing DirectorPreston Wells - CFORichard Newitter - Managing DirectorConference Call ParticipantsCaitlin Roberts - AnalystChris Pasquale - Senior Analyst for Medical Devices & SuppliesDanielle Antalffy - AnalystDrew Ranieri - AnalystJeff Johnson - Analyst ...

Stryker (NYSE:SYK) Q4 2025 Earnings call January 29, 2026 04:30 PM ET Speaker2Welcome to the fourth quarter and full year 2025 Stryker Earnings Call. My name is Layla, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Following the conference, we will conduct a question-and-answer session. This conference call is being recorded for replay purposes. Before we begin, I would like to remind you that the discussions during this conference call will include for ...

| | Fourth Quarter Net Sales Growth Overview | | | | | | --- | --- | --- | --- | --- | --- | | | Foreign Currency | | Acquisitions / | | | | | Exchange Constant Currency | Reported | Divestitures | | Organic | | MedSurg and Neurotechnology | | 17.5 % 0.9 % | 16.6 % | 4.0 % | 12.6 % | | Orthopaedics | | 2.2 1.3 | 0.9 | (7.5) | 8.4 | | Total | | 11.4 % 1.0 % | 10.4 % | (0.6)% | 11.0 % | Full Year Results | | Full Year Net Sales Growth Overview | | | | | | --- | --- | --- | --- | --- | --- | | | Foreign Curren ...

Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Con ...